Stockman Wealth Management, Inc. Pfizer Inc Transaction History

Stockman Wealth Management, Inc.

$554 Million
Q2 2024

A detailed history of Stockman Wealth Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Stockman Wealth Management, Inc. holds 276,902 shares of PFE stock, worth $8.06 Million. This represents 1.4% of its overall portfolio holdings.

Number of Shares

276,902

Previous 260,087 6.47%

Holding current value

$8.06 Million

Previous $7.22 Million 7.34%

% of portfolio

1.4%

Previous 1.32%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$25.26 - $29.6 $424,746 - $497,724	16,815 Added 6.47%	276,902 $7.75 Million
Q1 2024 Apr 17, 2024	BUY	$25.89 - $29.73 $1.02 Million - $1.17 Million	39,327 Added 17.81%	260,087 $7.22 Million
Q4 2023 Feb 01, 2024	BUY	$26.13 - $33.94 $315,859 - $410,266	12,088 Added 5.79%	220,760 $6.36 Million
Q3 2023 Oct 31, 2023	BUY	$32.09 - $37.51 $328,280 - $383,727	10,230 Added 5.16%	208,672 $6.92 Million
Q2 2023 Aug 02, 2023	BUY	$36.12 - $41.79 $367,846 - $425,589	10,184 Added 5.41%	198,442 $7.28 Million
Q1 2023 May 04, 2023	BUY	$39.39 - $51.28 $214,478 - $279,219	5,445 Added 2.98%	188,258 $7.68 Million
Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $273,838 - $357,465	-6,559 Reduced 3.46%	182,813 $9.37 Million
Q3 2022 Nov 07, 2022	BUY	$43.76 - $53.42 $434,186 - $530,033	9,922 Added 5.53%	189,372 $8.29 Million
Q2 2022 Jul 28, 2022	BUY	$46.53 - $55.17 $92,873 - $110,119	1,996 Added 1.12%	179,450 $9.41 Million
Q1 2022 May 05, 2022	SELL	$45.75 - $56.69 $60,573 - $75,057	-1,324 Reduced 0.74%	177,454 $9.19 Million
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $432,000 - $640,368	-10,455 Reduced 5.52%	178,778 $10.6 Million
Q3 2021 Nov 02, 2021	SELL	$39.25 - $50.42 $60,680 - $77,949	-1,546 Reduced 0.81%	189,233 $8.14 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $200,449 - $227,075	5,582 Added 3.01%	190,779 $7.47 Million
Q1 2021 May 05, 2021	BUY	$33.49 - $37.77 $702,318 - $792,074	20,971 Added 12.77%	185,197 $6.71 Million
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $330,415 - $420,152	9,872 Added 6.4%	164,226 $6.05 Million
Q3 2020 Nov 06, 2020	SELL	$31.75 - $37.25 $43,719 - $51,293	-1,377 Reduced 0.88%	154,354 $5.67 Million
Q2 2020 Aug 11, 2020	BUY	$30.12 - $36.54 $157,497 - $191,067	5,229 Added 3.47%	155,731 $5.09 Million
Q1 2020 May 06, 2020	BUY	$27.03 - $38.62 $67,926 - $97,052	2,513 Added 1.7%	150,502 $4.91 Million
Q4 2019 Feb 07, 2020	BUY	$32.92 - $37.36 $106,529 - $120,896	3,236 Added 2.24%	147,989 $5.8 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $544,012 - $705,424	16,744 Added 13.08%	144,753 $5.2 Million
Q2 2019 Aug 08, 2019	BUY	$36.98 - $41.52 $77,251 - $86,735	2,089 Added 1.66%	128,009 $5.55 Million
Q1 2019 May 07, 2019	SELL	$37.5 - $41.2 $125,587 - $137,978	-3,349 Reduced 2.59%	125,920 $5.35 Million
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $464,448 - $529,521	-12,073 Reduced 8.54%	129,269 $5.64 Million
Q3 2018 Nov 02, 2018	SELL	$34.47 - $41.81 $158,906 - $192,744	-4,610 Reduced 3.16%	141,342 $6.23 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $24,306 - $25,912	737 Added 0.51%	145,952 $5.3 Million
Q1 2018 May 10, 2018	BUY	$31.91 - $37.02 $152,976 - $177,473	4,794 Added 3.41%	145,215 $5.15 Million
Q4 2017 Feb 12, 2018	SELL	$33.26 - $35.29 $2,161 - $2,293	-65 Reduced 0.05%	140,421 $5.09 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $2.35 Million - $2.59 Million	75,743 Added 116.99%	140,486 $5.02 Million
Q2 2017 Aug 09, 2017	BUY	N/A	64,743	64,743 $2.18 Million

Others Institutions Holding PFE

# of Institutions

3,220

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $163B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stockman Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stockman Wealth Management, Inc. with notifications on news.

Account

Stockman Wealth Management, Inc. Pfizer Inc Transaction History